InvestSMART

Cochlear Limited (ASX: COH) - Announcements

Current share price for COH : $133.900 2.49 (1.83%)+

ASX company news and announcements for Cochlear Limited (COH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cochlear Limited (COH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cochlear Limited (COH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cochlear Limited (COH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$8,757 Appointment of Abbas Hussain to Cochlear Limited Board 20 Nov 2018 9:14AM $158.740 $133.900 fallen by 15.65%
$8,757 Appendix 3Y - Diggory Howitt 14 Nov 2018 9:54AM $168.020 $133.900 fallen by 20.31%
$8,757 COH Invest in Nyxoah 13 Nov 2018 8:49AM $175.450 $133.900 fallen by 23.68%
$8,757 Appendix 3B 12 Nov 2018 10:56AM $175.180 $133.900 fallen by 23.56%
$8,757 Appendix 3Y - Diggory Howitt 12 Nov 2018 9:50AM $176.130 $133.900 fallen by 23.98%
$8,757 Cochlear & GN Hearing Strengthen Tech & Commercial Alliance 8 Nov 2018 5:32PM $173.020 $133.900 fallen by 22.61%
$8,757 Appendix 3B 6 Nov 2018 2:21PM $172.320 $133.900 fallen by 22.30%
$8,757 COH - Ruling in USA Patent Infringement Case 5 Nov 2018 9:32AM $172.730 $133.900 fallen by 22.48%
$8,757 Appendix 3Y - Diggory Howitt 31 Oct 2018 5:25PM $177.580 $133.900 fallen by 24.60%
$8,757 Appendix 3Y - Bruce Robinson 31 Oct 2018 5:20PM $177.580 $133.900 fallen by 24.60%
$8,757 Appendix 3B 24 Oct 2018 9:30AM $173.230 $133.900 fallen by 22.70%
$8,757 Appendix 3Y - Bruce Robinson 23 Oct 2018 12:38PM $174.250 $133.900 fallen by 23.16%
$8,757 Appendix 3Z - Prof Edward Byrne 19 Oct 2018 2:29PM $184.130 $133.900 fallen by 27.28%
$8,757 Appendix 3B 19 Oct 2018 2:17PM $183.740 $133.900 fallen by 27.13%
$8,757 COH 2018 AGM - Results of Meeting 16 Oct 2018 3:14PM $186.380 $133.900 fallen by 28.16%
$8,757 2018 Cochlear AGM Presentation to Shareholders 16 Oct 2018 9:16AM $185.510 $133.900 fallen by 27.82%
$8,757 2018 Chairman's AGM Address to Shareholders 16 Oct 2018 9:16AM $185.510 $133.900 fallen by 27.82%
$8,757 Appendix 3B 11 Oct 2018 9:31AM $198.120 $133.900 fallen by 32.41%
$8,757 Appendix 3B 11 Oct 2018 9:29AM $198.120 $133.900 fallen by 32.41%
$8,757 Next phase development - totally implantable cochlear device 10 Oct 2018 8:27AM $191.880 $133.900 fallen by 30.22%
$8,757 Appendix 3B 24 Sep 2018 9:30AM $201.640 $133.900 fallen by 33.59%
$8,757 COH Chairman's Letter and Proxy/Voting Form 12 Sep 2018 2:00PM $205.830 $133.900 fallen by 34.95%
$8,757 COH Notice of Annual General Meeting 12 Sep 2018 1:59PM $205.780 $133.900 fallen by 34.93%
$8,757 Appendix 3B 3 Sep 2018 12:01PM $218.400 $133.900 fallen by 38.69%
$8,757 Appendix 3B 3 Sep 2018 9:13AM $215.810 $133.900 fallen by 37.95%

676 - 700 of 934 results

Page 28 of 38

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.